207 related articles for article (PubMed ID: 24046106)
1. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.
Collins AL; Wojcik S; Liu J; Frankel WL; Alder H; Yu L; Schmittgen TD; Croce CM; Bloomston M
Ann Surg Oncol; 2014 Jan; 21(1):133-8. PubMed ID: 24046106
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.
Schultz NA; Werner J; Willenbrock H; Roslind A; Giese N; Horn T; Wøjdemann M; Johansen JS
Mod Pathol; 2012 Dec; 25(12):1609-22. PubMed ID: 22878649
[TBL] [Abstract][Full Text] [Related]
3. Infiltration of peritumoural but tumour-free parenchyma with IgG4-positive plasma cells in hilar cholangiocarcinoma and pancreatic adenocarcinoma.
Resheq YJ; Quaas A; von Renteln D; Schramm C; Lohse AW; Lüth S
Dig Liver Dis; 2013 Oct; 45(10):859-65. PubMed ID: 23602806
[TBL] [Abstract][Full Text] [Related]
4. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic ductal adenocarcinoma and distal cholangiocarcinoma: a proposal of preoperative diagnostic score for differential diagnosis.
Muttillo EM; Ciardi A; Troiano R; Saullo P; Masselli G; Guida M; Tortora A; Sperduti I; Marinello G; Chirletti P; Caronna R
World J Surg Oncol; 2021 Jan; 19(1):10. PubMed ID: 33430887
[TBL] [Abstract][Full Text] [Related]
6. Analysis of MicroRNA in Bile Cytologic Samples Is Useful for Detection and Diagnosis of Extrahepatic Cholangiocarcinoma.
Uchihata Y; Arihiro K; Kaneko Y; Shimizu T; Marubashi Y; Aoki C; Murakami T; Ochi M; Niihara N; Ohtsuka K; Unehara R; Araki Y; Seki Y; Mori K; Oda M; Ishida K
Am J Clin Pathol; 2022 Jul; 158(1):122-131. PubMed ID: 35157005
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma".
Braxton DR; Saxe D; Damjanov N; Stashek K; Shroff S; Morrissette JD; Tondon R; Furth EE
Hum Pathol; 2017 Apr; 62():232-241. PubMed ID: 28232156
[TBL] [Abstract][Full Text] [Related]
8. Emerging Role of microRNA Dysregulation in Diagnosis and Prognosis of Extrahepatic Cholangiocarcinoma.
Prinz C; Frese R; Grams M; Fehring L
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011390
[TBL] [Abstract][Full Text] [Related]
9. The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma.
Hooper JE; Morgan TK; Grompe M; Sheppard BC; Troxell ML; Corless CL; Streeter PR
Hum Pathol; 2012 Oct; 43(10):1583-9. PubMed ID: 22406361
[TBL] [Abstract][Full Text] [Related]
10. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.
Puik JR; Meijer LL; Le Large TY; Prado MM; Frampton AE; Kazemier G; Giovannetti E
Pharmacogenomics; 2017 Sep; 18(14):1343-1358. PubMed ID: 28832247
[TBL] [Abstract][Full Text] [Related]
11. Subclassification and Detection of New Markers for the Discrimination of Primary Liver Tumors by Gene Expression Analysis Using Oligonucleotide Arrays.
Hass HG; Vogel U; Scheurlen M; Jobst J
Gut Liver; 2018 May; 12(3):306-315. PubMed ID: 29271183
[TBL] [Abstract][Full Text] [Related]
12. "OMICS" technologies and their role in foregut primary malignancies.
Farid SG; Morris-Stiff G
Curr Probl Surg; 2015 Oct; 52(10):409-41. PubMed ID: 26527526
[No Abstract] [Full Text] [Related]
13. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
14. Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma.
Lian Y; Zeng S; Wen S; Zhao X; Fang C; Zeng N
Technol Cancer Res Treat; 2023; 22():15330338231189399. PubMed ID: 37525872
[TBL] [Abstract][Full Text] [Related]
15. Small pancreatic carcinoma misdiagnosed as superficially spreading cholangiocarcinoma.
Igami T; Yokoyama Y; Nishio H; Ebata T; Shimoyama Y; Nakamura S; Nagino M
J Hepatobiliary Pancreat Surg; 2009; 16(4):579-84. PubMed ID: 19259611
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
Kitdumrongthum S; Metheetrairut C; Charoensawan V; Ounjai P; Janpipatkul K; Panvongsa W; Weerachayaphorn J; Piyachaturawat P; Chairoungdua A
Life Sci; 2018 Oct; 210():65-75. PubMed ID: 30165035
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling identifies microRNA signature in pancreatic cancer.
Lee EJ; Gusev Y; Jiang J; Nuovo GJ; Lerner MR; Frankel WL; Morgan DL; Postier RG; Brackett DJ; Schmittgen TD
Int J Cancer; 2007 Mar; 120(5):1046-54. PubMed ID: 17149698
[TBL] [Abstract][Full Text] [Related]
18. Albumin expression distinguishes bile duct adenomas from metastatic adenocarcinoma.
Moy AP; Arora K; Deshpande V
Histopathology; 2016 Sep; 69(3):423-30. PubMed ID: 26841202
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas.
Dumur CI; Campbell DJ; DeWitt JL; Oyesanya RA; Sirica AE
Exp Mol Pathol; 2010 Dec; 89(3):227-35. PubMed ID: 20816680
[TBL] [Abstract][Full Text] [Related]
20. Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.
McNally ME; Collins A; Wojcik SE; Liu J; Henry JC; Jiang J; Schmittgen T; Bloomston M
HPB (Oxford); 2013 Apr; 15(4):260-4. PubMed ID: 23458262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]